161609-97-8 Usage
Description
4-(4-METHYLSULFANYL-PHENYL)-PIPERIDINE HYDROCHLORIDE is a piperidine derivative with a hydrochloride salt, characterized as a white to off-white crystalline powder that is soluble in water and methanol. It has been studied for its potential pharmaceutical applications, particularly in the field of medicinal chemistry, and may serve as a building block in the synthesis of other organic compounds or in the development of new drugs. Further research and testing are required to fully understand its properties and potential uses.
Used in Pharmaceutical Industry:
4-(4-METHYLSULFANYL-PHENYL)-PIPERIDINE HYDROCHLORIDE is used as a chemical intermediate for the synthesis of other organic compounds, which can contribute to the development of new drugs and pharmaceutical agents.
Used in Medicinal Chemistry Research:
4-(4-METHYLSULFANYL-PHENYL)-PIPERIDINE HYDROCHLORIDE is used as a research compound to explore its potential applications in medicinal chemistry, with the aim of discovering its properties and possible uses in drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 161609-97-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,1,6,0 and 9 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 161609-97:
(8*1)+(7*6)+(6*1)+(5*6)+(4*0)+(3*9)+(2*9)+(1*7)=138
138 % 10 = 8
So 161609-97-8 is a valid CAS Registry Number.
161609-97-8Relevant articles and documents
Aryl substituted heterocycles
-
, (2008/06/13)
The present invention concerns the novel use of aryl substituted heterocycles of formula I, set out below, which antagonize the pharmacological actions of one of ent endogenous neuropeptide tachykinins an the neurokinin 2 (NK2) receptor making them useful whenever such antagonism is desired, such as in the treatment of asthma and related conditions. The invention also provides pharmaceutical compositions containing the aryl substituted heterocycles for use in such treatment. Certain novel aryl substituted heterocycles of formula I and novel intermediates for their manufacture are also provided. STR1